TAM
BLACU

Terrapin Asset Management’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Terrapin Asset Management’s Portfolio BLACU Stock Details BLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$323K Hold
30,000
– – 0.37% 39
2023
Q2 		$323K Hold
30,000
– – 0.42% 42
2023
Q1 		$309K Buy
+30,000
New +$307K 0.4% 48

Other funds holding BLACU

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Terrapin Asset Management's BLACU Position: Q3 2023 in Review

Terrapin Asset Management held its Bellevue Life Sciences Acquisition Corp. Unit (BLACU) position steady in Q3 2023 at 30,000 shares worth $323K. The position accounts for 0.37% of the portfolio, ranked #39.

Terrapin Asset Management first reported a position in BLACU in Q1 2023 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold BLACU as of Q3 2023.

  • Terrapin Asset Management held 30,000 shares of Bellevue Life Sciences Acquisition Corp. Unit worth $323K as of Q3 2023.
  • Terrapin Asset Management left its Bellevue Life Sciences Acquisition Corp. Unit share count unchanged in Q3 2023.
  • Bellevue Life Sciences Acquisition Corp. Unit made up 0.37% of Terrapin Asset Management's portfolio in Q3 2023, its #39 holding.
  • Terrapin Asset Management first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q3 2023.

Based on Terrapin Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.